GI
GlucoTrack Inc
🇺🇸XNAS.GCTKUnited StatesHealthcare
$2.31USDup +0.03 (+1.32%)OpenDelayed6:05 PM
Price$2.31+0.03 (+1.32%)
Profile
- Healthcare
- Medical Instruments & Supplies
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US45824Q5071
- CUSIP
- 45824Q507
Company
- Employees
- 15
- Headquarters
- Rutherford, United States
- Website
- https://glucotrack.com
- CEO
- Mr. Erik C. Emerson
Market
- Shares outstanding
- 798.1K
- Market cap
- $1.84M
Highlights
- Market cap
- $1.82M
- EPS LTM
- -$19.98calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.12calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$15.95M+40.43%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$16.31M-13.52%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.